Armin Schulz
Born in Mönchengladbach, he studied business administration in the Netherlands. In the course of his studies he came into contact with the stock exchange for the first time. He has more than 25 years of experience in stock market business.
After graduating, he worked as an IT consultant for a listed company before becoming self-employed, during which time he worked for various DAX-listed companies and a large Swiss insurance company, among others.
Since 2009, he has been exclusively involved in the capital markets, where he was able to gain experience as a day and swing trader, in investor relations and at board level. He was able to live out his passion for numbers in the controlling department of a securities trading house.
For him, fundamental analysis paired with the correct reading of the price action of a market provides the basis for successful trading.
Commented by Armin Schulz
Commented by Armin Schulz on January 14th, 2022 | 11:06 CET
Lufthansa, wallstreet:online, Block - Shares with catch-up potential
The nervousness was palpable as the US indices fell for five days in a row. Reasons for consolidation are quickly found - the Omicron variant, inflation and the fear of rising interest rates provide uncertainty for the bulls. Especially the big tech companies would suffer from an interest rate hike, and many tech stocks were already punished and investors preferred to invest in value stocks. If the interest rate hike comes, there will likely be further markdowns in the tech sector. Today, we look at three companies that we believe could be on the verge of a turnaround.
Read
Commented by Armin Schulz on January 12th, 2022 | 13:42 CET
Bayer, XPhyto Therapeutics, MorphoSys - Which pharmaceutical companies bring returns?
Most recently, the pharmaceutical industry has been accused of being greedy and getting rich off Corona. While it is true that 2021 has been dominated by vaccine news, the industry can do much more than just produce vaccines against Corona. Handelsblatt ran a headline on January 10, "In the shadow of Corona," citing the growing number of cancers over the past several years. This year, more than 45 new drugs are expected to hit the market to help fight cancer and genetic defects, among other things. Today, we look at three companies that do not make Corona vaccines.
Read
Commented by Armin Schulz on January 10th, 2022 | 11:14 CET
Alibaba, Hong Lai Huat, Xiaomi - Asian stocks catching up?
The year 2021 was often a year to forget for investors in the Asian region. Chinese stocks, in particular, suffered from government regulation, causing many stocks to plummet despite good numbers. After the dip in 2020 due to the Corona pandemic, the economy made significant gains, but this rapid growth will not continue so quickly in 2022. Nevertheless, the first investors are sensing a trend reversal due to the discrepancy in stock market developments. While the US stock market climbed strongly in 2021, the Hang Seng fell 13% plus. There has not been such a difference since the Asian crisis. We take a look at three interesting shares from the Asian region.
Read
Commented by Armin Schulz on January 7th, 2022 | 13:53 CET
Lufthansa, Prospect Ridge Resources, S&T - Profits beckon here
2022 is beginning like 2021 - Corona is still the number one topic. Despite the pandemic, one can draw hope from the past year because, despite all adversities, the shares have, in part, made very decent gains. Now, with Omicron, endemicity seems possible. The virus is more contagious, but the course is milder than the previous variants. Infection could bring about the herd immunity that has long been longed for. In addition to Corona, however, one must also keep an eye on inflation. It has been taking hold since mid-2021 and will continue to occupy us in 2022. The question on all investors' minds is: where do the gains beckon in the coming year? Today, we highlight three possible winners.
Read
Commented by Armin Schulz on January 5th, 2022 | 09:02 CET
Gazprom, Almonty Industries, Standard Lithium - Investing in commodities with high demand
2021 was the year of skyrocketing commodity prices. Many different factors played a role. One, of course, was the Corona pandemic, which caused many companies to cut back on production. As the economy recovered faster than expected, markets were undersupplied. In addition, there were supply chain difficulties, natural disasters, and export restrictions, and this is where some of the dependencies on China became apparent. Currently, too little magnesium is being produced because the Middle Kingdom is suffering from electricity shortages. Today we look at three commodity producers for which we expect demand to remain high in 2022.
Read
Commented by Armin Schulz on January 3rd, 2022 | 08:59 CET
Bayer, Memiontec, Deutsche Telekom - With blue chips through inflation
When inflation rates started to rise in the USA and Germany, all sides initially said this phenomenon was temporary. In the meantime, it has become clear that the experts were wrong. Inflation has come to stay and brings inflation rates we have not seen for decades. In November, it was 5.2% in Germany. Typically, it would be the ECB's job to control inflation, but its hands are tied because of the interest rate problem. That leaves investors with the question of how best to protect their money. One option is to look at blue chips, three of which we will examine in more detail today.
Read
Commented by Armin Schulz on December 30th, 2021 | 11:35 CET
Standard Lithium, Manganese X Energy, Daimler Truck - The future of the battery
Electric cars would never have existed with the conventional lead-acid batteries popularly used in remote controls and the like. The development only became possible with the invention of lithium-ion batteries, which can be charged much more often and thus significantly increase battery life. The advantage of electric mobility is emission-free driving. The disadvantage is longer refueling times, shorter range and the need for lithium and other rare raw materials, such as manganese. It is precisely the batteries that make electromobility so expensive. It is not for nothing that Tesla is trying to push the price down to under USD 100 per kilowatt-hour. Experts expect that the prices of internal combustion and e-cars will then converge.
Read
Commented by Armin Schulz on December 29th, 2021 | 10:26 CET
TeamViewer, Aspermont, ProSiebenSat.1 Media - Digital business models booming
The Corona Crisis has shown that digital business models are booming, whereas conventional business models suffered from the lockdown. If you want to look at it positively, the crisis has led to a digitalization push and new business models. Restaurants suddenly switched to online ordering, seminars are held online, and virtual trade shows are also on the rise. On the stock market, too, some companies are increasingly focusing on digitized business models. Today we take a closer look at three of them.
Read
Commented by Armin Schulz on December 28th, 2021 | 11:30 CET
Tesla, Altech Advanced Materials, BYD - The battle for the battery of the future
Since climate change has become the focus of public attention, the goal of many countries is to reduce emissions. The transportation sector is the second-largest CO2 emitter; this includes motor vehicles. E-cars still cost significantly more than the conventional combustion engine because their batteries are still so expensive. Called out are costs under USD 100 per kilowatt-hour to bring the two vehicles together in price. Many different battery manufacturers are trying to improve the battery. Ideally, more energy can be stored, promising more range, the lifespan should be increased, and the batteries should become safer. Today, we look at three companies that have already made it a good bit of the way.
Read
Commented by Armin Schulz on December 27th, 2021 | 09:03 CET
Infineon, BrainChip, Nvidia - The chip market remains hot
First and foremost, the automotive sector suffered from a lack of chips in 2021. Blaming everything on Corona alone is too short-sighted. The pandemic is certainly a factor, but the rapid economic recovery caught companies off guard. Added to this was digitization, partly also pandemic-related, which boosted demand for semiconductors more than the already high structural semiconductor demand. A few weather-related production stoppages and disrupted supply chains later, the situation was as it currently stands. Intel does not expect the situation to slowly calm down until 2023. Reason enough to take a look at three chip manufacturers.
Read